California 2025-2026 Regular Session

California Assembly Bill AB1864

Introduced
2/11/26  
Refer
2/23/26  
Report Pass
3/25/26  
Refer
3/25/26  
Report Pass
4/22/26  

Caption

Gene synthesis equipment manufacturers and providers.

Impact

The bill strengthens existing laws related to gene synthesis and requires adherence to a regulatory framework designed to ensure safety and mitigate risks associated with synthetic nucleic acids. By implementing compliance standards, the bill aims to prevent reckless or malicious actions from individuals or companies that could endanger public health. The State Department of Public Health will have the authority to adapt regulations relating to the framework, potentially integrating federal standards that achieve an equal or greater level of protection for Californians.

Summary

Assembly Bill 1864, introduced by Assembly Member Berman, aims to regulate the manufacture and provision of benchtop nucleic acid synthesis equipment in California. The bill mandates that manufacturers must comply with a specific framework known as the Framework for Nucleic Acid Synthesis Screening, as revised in September 2024, before producing or selling these products in the state. This legislation is rooted in the state's commitment to protecting its residents from potential biohazards arising from the misuse of synthetic nucleic acids, which could lead to dangerous biological risks.

Contention

While the bill is intended to enhance safety measures, it may face scrutiny from manufacturers regarding the feasibility of compliance with such stringent regulations. Critics may argue that the increased regulatory environment could inhibit innovation in the biotechnology sector. The potential civil penalties for violations, which may reach up to $1,000 per day, could also be seen as a deterrent for manufacturers operating within the state, raising concerns over the balance between regulation and industry growth. Furthermore, the nuances surrounding the definition of the framework may provoke discussions about the appropriateness and sufficiency of the proposed guidelines.

Companion Bills

No companion bills found.

Previously Filed As

CA S09279

Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.

CA SB4446

PRESS Act Preventing Rogue Equipment for Synthetic Substances Act

CA HB7184

PRESS Act Preventing Rogue Equipment for Synthetic Substances Act

CA A03283

Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.

CA HB1269

Require that manufacturers of agricultural equipment allow an independent repair provider or an owner to make certain repairs to agricultural equipment.

CA AB1181

Firefighters: personal protective equipment.

CA SB2024

Pharmaceutical products; requiring publishing of certain information by manufacturers. Effective date.

CA H7476

Provides that original equipment manufacturers, implemented by/with surrogate distributors, of agricultural equipment, provide to independent service providers repair information and tools to maintain and repair electronics-enabled agricultural equipment.

CA S3117

Provides that original equipment manufacturers, implemented by/with surrogate distributors, of agricultural equipment, provide to independent service providers repair information and tools to maintain and repair electronics-enabled agricultural equipment.

CA H5159

Provides that original equipment manufacturers, implemented by/with surrogate distributors, of agricultural equipment, provide to independent service providers repair information and tools to maintain and repair electronics-enabled agricultural equipment.

Similar Bills

US HB2997

Green Climate Fund Authorization Act of 2025

HI SB2585

Relating To Artificial Intelligence.

NY S09279

Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.

WV SB808

Regulating consumable hemp products

US SR36

A resolution expressing the sense of the Senate that the United States, States, cities, Tribal nations, businesses, institutions of higher education, and other institutions in the United States should work toward achieving the goals of the Paris Agreement.

MN HF3452

Kratom classified as a Schedule II controlled substance.

MN SF3711

Kratom classification as a Schedule II controlled substance

LA SB154

Criminalizes the possession or distribution of kratom. (8/1/25)